Latest period
$120.16M
YoY change
+57.7%
5Y CAGR
+33.4%
Peak year (2025)
$152.71M
Latest annual
$152.71M
Stock-Based Compensation history chart for Insmed (INSM) from 1999 to 2025
Latest: $152.71M
Stock-Based Compensation growth chart for Insmed (INSM) from 1999 to 2025
Latest: +57.7%
Stock-Based Compensation history table for Insmed (INSM) from 1999 to 2025
| 2025 | $152.71M | +57.7% | +$55.88M | ||
| 2024 | $96.83M | +29.5% | +$22.06M | ||
| 2023 | $74.78M | +29.6% | +$17.09M | ||
| 2022 | $57.69M | +25.3% | +$11.66M | ||
| 2021 | $46.02M | +27.3% | +$9.86M | ||
| 2020 | $36.16M | +34.1% | +$9.19M | ||
| 2019 | $26.97M | +2.8% | +$731.00K | ||
| 2018 | $26.24M | +45.2% | +$8.17M | ||
| 2017 | $18.07M | +0.2% | +$34.00K | ||
| 2016 | $18.04M | +15.7% | +$2.45M | ||
| 2015 | $15.59M | +37.6% | +$4.26M | ||
| 2014 | $11.33M | +30.7% | +$2.66M | ||
| 2013 | $8.67M | +190.8% | +$5.69M | ||
| 2012 | $2.98M | +86.4% | +$1.38M | ||
| 2011 | $1.60M | +336.9% | +$1.23M | ||
| 2010 | $366.00K | -85.6% | −$2.18M | ||
| 2009 | $2.54M | +199.1% | +$1.69M | ||
| 2008 | $850.00K | +63.1% | +$329.00K | ||
| 2007 | $521.00K | -41.1% | −$364.00K | ||
| 2006 | $885.00K | — | +$885.00K | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | -100.0% | −$95.00K | ||
| 2002 | $95.00K | 0.0% | $0.00 | ||
| 2001 | $95.00K | — | +$95.00K | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | — |
- 2025$152.71M+57.7%
- 2024$96.83M+29.5%
- 2023$74.78M+29.6%
- 2022$57.69M+25.3%
- 2021$46.02M+27.3%
- 2020$36.16M+34.1%
- 2019$26.97M+2.8%
- 2018$26.24M+45.2%
- 2017$18.07M+0.2%
- 2016$18.04M+15.7%
- 2015$15.59M+37.6%
- 2014$11.33M+30.7%
- 2013$8.67M+190.8%
- 2012$2.98M+86.4%
- 2011$1.60M+336.9%
- 2010$366.00K-85.6%
- 2009$2.54M+199.1%
- 2008$850.00K+63.1%
- 2007$521.00K-41.1%
- 2006$885.00K—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00-100.0%
- 2002$95.00K0.0%
- 2001$95.00K—
- 2000$0.00—
- 1999$0.00—
Stock-Based Compensation values are taken from Insmed's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Insmed (INSM)
Stock-Based Compensation for Insmed (INSM): headline value $120.16M · YoY +57.7%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Insmed (INSM) stock-based compensation totalled $152.71M – surged 57.7% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Insmed stock-based compensation compounded at +33.4% per year, with mixed annual results across the window.
The record annual stock-based compensation stands at $152.71M, reached in 2025; the historical low of $0.00 was recorded in 1999.
Insmed Stock-Based Compensation by Year
Insmed Stock-Based Compensation 2025: $152.71M
Insmed posted stock-based compensation of $152.71M in 2025, surged 57.7% from 2024. This figure represents the highest annual value in the available history.
Insmed Stock-Based Compensation 2024: $96.83M
In 2024, Insmed reported stock-based compensation of $96.83M, grew 29.5% from 2023.
Insmed Stock-Based Compensation 2023: $74.78M
Insmed stock-based compensation in 2023 was $74.78M, grew 29.6% from 2022.
Insmed Stock-Based Compensation 2022: $57.69M
2022's stock-based compensation for Insmed came in at $57.69M, grew 25.3% from 2021.
Insmed Stock-Based Compensation 2021: $46.02M
Insmed stock-based compensation in 2021 was $46.02M.
See more financial history for Insmed (INSM).
Sector peers by Stock-Based Compensation
Healthcare peers of Insmed (INSM), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
Insmed (INSM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation